Back to top

Image: Bigstock

Hill-Rom Holdings, Inc.

Read MoreHide Full Article

Over the last three months, Hill-Rom is trading above the broader Medical Product industry. Management is currently looking to gain traction in the untapped international market with its efficient international team and organizational realignment. The company also continues to grow on its strategy of product expansion and diversification with recent launch of its surgical beds. Notably, the company demonstrated balanced growth across all three segments in its last reported fiscal second quarter. Geographically, over the recent past, Hill-Rom consistently posted strong growth in the U.S. and also delivered a solid gross margin. Management’s outlook for 2017 also raises optimism. However, the company has faced difficulties in the Asia-Pacific region of late. Also, with more than 30% sales generating outside, Hill-Rom faces hitch related to adverse currency fluctuations. The highly competitive market is a major concern.

Published in